Carmat

Carmat is a French medical technology company specializing in the development and commercialization of the Aeson®, a total artificial heart designed to provide a lasting solution for patients suffering from end-stage biventricular heart failure. Their innovative technology aims to be the primary alternative to heart transplants, offering hope to those who are not eligible for or have exhausted other treatment options. Carmat's vision is to revolutionize the healthcare industry by providing a life-saving and life-enhancing solution for individuals struggling with this debilitating condition.

The company has a strong commitment to research and development, evidenced by their ongoing clinical trials and partnerships with leading medical institutions. They have a dedicated team of engineers, scientists, and clinicians working tirelessly to improve the Aeson® and ensure its safety and efficacy. Carmat is currently commercially available in Europe and is undergoing clinical trials in the United States. Their continued growth and development promise to make a significant impact on the lives of countless individuals battling heart failure.

Carmat offers a variety of work arrangements, including home office options with business trips within EMEA and Germany. Some roles are based in Vélizy-Villacoublay or Bois d’Arcy, indicating a blend of on-site and remote work possibilities. The company's commitment to agility and adaptation suggests a flexible approach to employee needs and preferences.

Carmat's mission is to provide cardiologists with innovative technologies that save lives and improve the quality of life for patients with advanced heart failure. They are committed to developing a total artificial heart, Aeson®, as a primary alternative to heart transplants for those suffering from end-stage biventricular heart failure, a condition with limited treatment options.

Carmat fosters a culture that prioritizes excellence, innovation, and a positive, open-minded approach to tackling challenges. Their core values emphasize proactivity, problem-solving, agility, and integrity, encouraging collaboration and communication. This dynamic and stimulating environment is built on trust and a shared commitment to providing patients and physicians with an alternative treatment for end-stage heart failure.

Carmat actively promotes a culture of diversity, equity, and inclusion through its core values of Open and Trust. They encourage diverse perspectives and opinions within their team to spark innovation and foster a respectful, ethical environment where open communication thrives. Their efforts are evident in their commitment to equal opportunities for all employees and their proactive recruitment practices, as shown by their strong score on the French Gender Equality Index.